IMU 1.45% 6.8¢ imugene limited

B-vaxx - a sleeper surprise?, page-48

  1. 211 Posts.
    lightbulb Created with Sketch. 395
    Davy and others
    The B-Vaxx trial is very interesting to me . Its still going. Patients are still being treated.
    My wife worked in Cancer wards for years.
    The data should be very interesting to our world class science staff researchers.
    If a patient reaches 5 Years without cancer it was called remission. Its now called No Evidence of Disease(NED)
    So when a trial is going up near 5 years we could actually see some results that mention the word cure or NED. Now that will blow peoples minds.

    The mind blowing results IMU are having in the small trials they are running all goes well.

    I am just sitting back waiting for PD1 to kick through to Phase 2. It can treat multiple cancers without toxicity. Hervaxx should be licensed out and BVaxx may be that one that just surprises everyone.
    In any case I will also be keeping an eye on BVaxx for a surprise or two for us all and its patients.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
6.8¢
Change
-0.001(1.45%)
Mkt cap ! $508.7M
Open High Low Value Volume
6.9¢ 7.1¢ 6.7¢ $1.107M 16.01M

Buyers (Bids)

No. Vol. Price($)
20 1972207 6.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.9¢ 936298 24
View Market Depth
Last trade - 15.26pm 22/05/2024 (20 minute delay) ?
Last
6.8¢
  Change
-0.001 ( 1.59 %)
Open High Low Volume
7.0¢ 7.1¢ 6.7¢ 8693677
Last updated 15.44pm 22/05/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.